US5011471027
US5011471027
Krystal Biotech, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 389.130.000 | 290.515.000 | 33.9% |
| Cost of Revenue | 23.049.000 | 20.061.000 | 14.9% |
| Gross Profit | 366.081.000 | 270.454.000 | 35.4% |
| 204.786.000 | 167.206.000 | 22.5% | |
| Operating Income | 161.295.000 | 103.248.000 | 56.2% |
| Pretax Income | 189.471.000 | 95.356.000 | 98.7% |
| Net Income Common Stockholders | 204.831.000 | 89.159.000 | 129.7% |
| -- | -- | -- | |
| -- | -- | -- |